Patricia L. Nash, MD :: Nationwide Children’s Hospital, Columbus, Ohio

Contact Information

Developmental Behavioral Pediatrics
700 Children's Dr
Columbus, OH 43205 [ map ]
PH: (614) 722-5725
FX: (614) 722-4966


Patricia L. Nash, MD, is a member of the Section of Developmental and Behavioral Pediatrics at Nationwide Children’s Hospital and a Clinical Associate Professor of Pediatrics at The Ohio State University College of Medicine. Her primary clinical, research and educational activities include attention deficit hyperactivity disorder, autism and Down syndrome. Dr. Nash received her medical degree from the Indiana University School of Medicine in Indianapolis and completed the pediatric residency program at Indiana University Medical Center, followed by a fellowship in behavioral and developmental pediatrics at The Ohio State University College of Medicine and Nationwide Children’s Hospital. She serves as the Director of the Down Syndrome Clinic.


  • Female

Languages Spoken:

  • English

Education and Training

Medical School

  • Indiana University School of Medicine
    Date Completed: 06/30/1990


  • Indiana University Medical Center
    Date Completed: 06/30/1991


  • Indiana University Medical Center
    Date Completed: 06/30/1993


  • Nationwide Children's Hospital
    Date Completed: 06/30/2000


  • Pediatrics


  • Developmental Behavioral Pediatrics


  • Developmental Behavioral Pediatrics

Date of Appointment at Nationwide Children’s Hospital:

  • 03/30/2001


  • Beunders G, Voorhoeve E, Golzio C, Pardo LM, Rosenfeld JA, Talkowski ME, Simonic I, Lionel AC, Vergult S, Pyatt Re, Van de Kamp J, Nieuwint A, Weiss MM, Rizzu P, Verwer LE, van Spaendonk RM, Shen Y, Wu BL, Yu T, Yu Y, Chiang C, Gusella JF, Lindgren AM, Morton CC, van Binsbergen E, Bulk S, van Rossem E, Vanakker O, Armstrong R, Park Sm, Greenhaigh L, Maye U, Neill NJ, Abbott KM, Sell S, LAdda R, Farber DM, Bader PL, Cushing T, Drautz JM, Konczal L, Nash P, de Los Reys E, Carter MT, Hopkins E, Marshall CR, Osborne LR, Gripp KW, Thrush DL, Hashimoto S, Gastier-Foster JM, Astbury C, Ylstra B, Meijers-Heijboer H, Posthuma D, Menten B, Mortier G, Scherer SW, Eicheler EE, Girirajan S, Katsanis N, Groffen AJ, Sistermans EA, Am J Hum Genet. 2013. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus.  PubMed - indexed for MEDLINE. Vol. 7;92(2), no. January: 210-20.
  • Cua CL, Rogers LK, Chicoine LG, Augustine M, Jin Y, Nash PL, Nelin LD. 2010. Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine.  Eur J Pediatr.
  • Aman MG; Hollway JA; Leone S; Masty J; Lindsay R; Nash P; Arnold LE. 2009. Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children.  Research In Developmental Disabilities. Vol. 30, no. 2. (March): 386-396.
  • Baum RA; Nash PL; Foster JE; Spader M; Ratliff-Schaub K; Coury DL. 2008. Primary care of children and adolescents with down syndrome: an update.  Current Problems In Pediatric And Adolescent Health Care. Vol. 38, no. 8. (September): 241-261.
  • Cua CL; Cooke G; Taylor M; Hayes J; Waldon L; Lipowski P; Kossman B; Nash PL. 2006. Endothelial nitric oxide synthase polymorphisms associated with abnormal nitric oxide production are not over-represented in children with Down syndrome.  Congenital Heart Disease. Vol. 1, no. 4. (July): 169-174.
  • Aman MG; Arnold LE; McDougle CJ; Vitiello B; Scahill L; Davies M; McCracken JT; Tierney E; Nash PL; Posey DJ; Chuang S; Martin A; Shah B; Gonzalez NM; Swiezy NB; Ritz L; Koenig K; McGough J; Ghuman JK; Lindsay RL. 2005. Acute and long-term safety and tolerability of risperidone in children with autism.  Journal Of Child And Adolescent Psychopharmacology. Vol. 15, no. 6. (December): 869-884.
  • Aman, M. G., Arnold, L.E., Lindsay, R.L., Nash, P.L., et al. 2005. Risperidone Treatment of Autistic Disorder: Longer Term Benefits and Blinded Discontinuation After Six Months.  American Journal of Psychiatry. Vol. 162, no. January: 1361-1369.
  • Coury DL; Nash PL. 2003. Epidemiology and Etiology of Autistic Spectrum Disorders.  Pediatric Annals. Vol. 32, no. 10. (October): 696-700.
  • Nash PL; Coury DL. 2003. Screening tools assist with diagnosis of autistic spectrum disorders.  Pediatric Annals. Vol. 32, no. 10. (October): 664-670.
  • Aman, M.G., Lindsay, R. L., Nash, P. L., et al. 2003. Individuals with Mental Retardation. In Pediatric Psychopharmacology Principles and Practice. Edited by A. Martin, L. Scahill, D.S. Charney, J.L. Leckman. Oxford: Oxford University Press.
  • McCracken JT; McGough J; Shah B; Cronin P; Hong D; Aman MG; Arnold LE; Lindsay R; Nash P; Hollway J; McDougle CJ; Posey D; Swiezy N; Kohn A; Scahill L; Martin A; Koenig K; Volkmar F; Carroll D; Lancor A; Tierney E; Ghuman J; Gonzalez NM; Grados M; Vitiello B; Ritz L; Davies M; Robinson J; McMahon D. 2002. Risperidone in children with autism and serious behavioral problems.  The New England Journal Of Medicine. Vol. 347, no. 5. (December): 314-321.
  • Aman, M.G., Lindsay, R. L., Nash, P. L., et al. 2002. Pharmacotherapy of children with mental retardation. In Textbook of Child and Adolescent Psychopharmacology.. Edited by A. Martin, L. Scahill, D. Charney, & J.F. Leckman. New York, NY: Oxford University Press.
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000